Human placenta-derived cells have mesenchymal stem/progenitor cell potential

Stem Cells
Yumi FukuchiKohichiro Tsuji

Abstract

Mesenchymal stem/progenitor cells (MSCs) are widely distributed in a variety of tissues in the adult human body (e.g., bone marrow [BM], kidney, lung, and liver). These cells are also present in the fetal environment (e.g., blood, liver, BM, and kidney). However, MSCs are a rare population in these tissues. Here we tried to identify cells with MSC-like potency in human placenta. We isolated adherent cells from trypsin-digested term placentas and established two clones by limiting dilution. We examined these cells for morphology, surface markers, gene expression patterns, and differentiation potential and found that they expressed several stem cell markers, hematopoietic/ endothelial cell-related genes, and organ-specific genes, as determined by reverse transcription-polymerase chain reaction and fluorescence-activated cell sorter analysis. They also showed osteogenic and adipogenic differentiation potentials under appropriate conditions. We suggest that placenta-derived cells have multilineage differentiation potential similar to MSCs in terms of morphology, cell-surface antigen expression, and gene expression patterns. The placenta may prove to be a useful source of MSCs.

References

Apr 2, 1999·Science·M F PittengerD R Marshak
Jun 10, 2000·British Journal of Haematology·A EricesJ J Minguell
Sep 16, 2000·Experimental Hematology·R J Deans, A B Moseley
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·M SchuldinerN Benvenisty
Nov 1, 2000·Arthritis Research·N J ZvaiflerR N Maini
Apr 27, 2001·Mechanisms of Ageing and Development·M S Rao, M P Mattson
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·D S KaufmanJ A Thomson
Feb 2, 2002·Experimental Hematology·Amelia BartholomewRonald Hoffman
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Shulamit LevenbergRobert Langer
Jun 22, 2002·Nature·Yuehua JiangCatherine M Verfaillie
Dec 17, 2002·Experimental Hematology·Graça Almeida-PoradaEsmail D Zanjani

❮ Previous
Next ❯

Citations

Oct 29, 2005·Bulletin of Experimental Biology and Medicine·Yu A RomanovL B Buravkova
Aug 26, 2006·Bulletin of Experimental Biology and Medicine·R A MusinaG T Sukhikh
Apr 7, 2007·Bulletin of Experimental Biology and Medicine·Yu A RomanovO A Antonova
Jun 6, 2009·Bulletin of Experimental Biology and Medicine·A A OstaninE R Chernykh
Sep 14, 2010·Cytotechnology·Sangeetha HareendranPrithi Rajan
Oct 1, 2013·Journal of Materials Science. Materials in Medicine·Malgorzata Lewandowska-Szumiel, Ilona Kalaszczynska
Jun 18, 2011·Frontiers of Medicine·Ranhua JiangZhong Chao Han
May 29, 2012·Journal of Molecular Neuroscience : MN·Yonit Fisher-ShovalDaniel Offen
Jan 18, 2013·DNA and Cell Biology·Maristela Maria MartiniMarcio Alvarez-Silva
Jan 23, 2013·Stem Cells and Development·Joong Hyun ShimDong Wook Shin
Jan 23, 2013·Stem Cells and Development·Raquel CalloniDiego Bonatto
Aug 4, 2011·Tissue Engineering. Part B, Reviews·Ana Rita Costa-PintoNuno M Neves
Jun 11, 2008·Human Reproduction·Jeong Hee MoonHae Kwon Kim
Sep 13, 2006·Implant Dentistry·Dennis Smiler, Muna Soltan
Mar 23, 2010·Current Opinion in Obstetrics & Gynecology·Hongling Du, Hugh S Taylor
Aug 27, 2010·Journal of the Royal Society, Interface·Hassan AbdulrazzakPascale V Guillot
Apr 27, 2007·American Journal of Nephrology·Shunsuke Ohnishi, Noritoshi Nagaya
Feb 12, 2009·Reproductive Sciences·Alicia BárcenaSusan J Fisher

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.